KPV

What Is KPV?

KPV is a naturally occurring tripeptide composed of three amino acids — lysine, proline, and valine — representing the C-terminal fragment of alpha-melanocyte stimulating hormone (α-MSH). It was identified as the active anti-inflammatory core of α-MSH: retaining the hormone's powerful anti-inflammatory and immune-modulating properties while eliminating the melanin-stimulating (skin darkening) and appetite-affecting actions that make the full α-MSH molecule impractical for most therapeutic applications.

KPV's small molecular size, natural origin, and multi-route administration options (subcutaneous, oral, and topical) make it one of the most versatile anti-inflammatory peptides in the research catalogue. It is particularly valued for its affinity for gastrointestinal tissue — where it directly addresses gut inflammation, mucosal repair, and intestinal barrier integrity — as well as its potent effects on skin inflammation, wound healing, and systemic inflammatory conditions.

Unlike conventional anti-inflammatory medications (NSAIDs, corticosteroids), KPV does not simply suppress inflammation indiscriminately — it selectively resets overactive immune responses, allowing the body's normal healing processes to proceed while reducing the pathological inflammatory burden.

---

How It Works — Mechanism of Action

1. Inhibits NF-κB — The Master Switch of Inflammation NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is the master transcriptional regulator of the inflammatory response — it controls the expression of the primary pro-inflammatory cytokines that drive acute and chronic inflammation throughout the body. KPV directly inhibits NF-κB activation, producing downstream reductions in:

• TNF-α (tumour necrosis factor alpha)
• IL-6 (interleukin-6)
• IL-1β (interleukin-1 beta)
• COX-2 (cyclooxygenase-2)

This mechanism is broader and more fundamental than the action of NSAIDs, which inhibit only COX enzymes.

2. Melanocortin Receptor Activity (MC1R & MC3R) KPV acts on MC1R and MC3R receptors expressed on immune cells and inflammatory tissues. Activation of these receptors reduces the release of pro-inflammatory molecules and modulates immune cell behaviour — shifting the immune response from a destructive inflammatory state toward a controlled, resolution-oriented state.

3. Intestinal Barrier Repair One of KPV's most clinically significant mechanisms: it restores tight junction integrity between intestinal epithelial cells. Tight junctions are the structural seals that prevent undigested food particles, bacteria, and toxins from crossing the gut lining into systemic circulation. When tight junctions are compromised — in leaky gut, IBD, or post-antibiotic states — systemic inflammation escalates. KPV repairs this barrier directly, addressing the root cause rather than just the symptoms.

4. Skin Healing & Anti-Redness Both topically and systemically, KPV suppresses inflammatory skin pathways without the thinning and adrenal suppression side effects of steroid-based treatments. It improves:

• Eczema, psoriasis, and dermatitis
• Acne-related inflammation
• Wound healing quality and speed
• Post-procedure redness and recovery (laser, microneedling, chemical peels)

5. Gut-Brain Axis Support By reducing gut permeability and inflammatory signalling in the enteric nervous system, KPV indirectly improves mood, cognitive clarity, and stress tolerance — reflecting the well-established gut-brain axis relationship.

6. Antimicrobial Properties Research suggests KPV exerts mild antimicrobial activity, further supporting tissue healing by limiting pathogen-driven inflammation at wound and gut tissue sites.

---

Research-Backed Benefits

Gastrointestinal Health

• IBS and functional gut disorder management
• Inflammatory Bowel Disease (IBD): promising preclinical results for ulcerative colitis and Crohn's disease
• Gut barrier function restoration — repairs intestinal permeability (leaky gut)
• Post-antibiotic gut recovery — accelerates microbiome and mucosal recovery after antibiotic courses
• Oral delivery is viable — KPV appears stable in the gastrointestinal tract, retaining activity in gut tissue when taken by mouth

Skin & Dermatology

• Eczema, psoriasis, and dermatitis — significant reduction in inflammation and redness
• Wound healing — accelerated healing with reduced inflammation and scarring
• Acne — anti-inflammatory effect reduces lesion severity and redness
• Rosacea — measurable reduction in facial redness and inflammatory flare frequency
• Post-cosmetic procedure healing — enhanced recovery and reduced downtime

Systemic Anti-Inflammatory

• Joint health — reduces inflammation in arthritic and overuse joint conditions
• Autoimmune modulation — rebalances overactive immune responses without full immunosuppression
• Neuroinflammation — potential support for brain inflammation (animal models)
• Cardiovascular protection — anti-inflammatory effects in vascular tissue
• General systemic inflammation reduction — improved inflammatory biomarkers in research models

---

Dosing & Administration

Note: KPV has no standardised clinical dosing guidelines. The following reflects preclinical research protocols and exploratory experimental use. Always work with a qualified healthcare professional.

Subcutaneous Injection (Systemic Use)

• Dose: 0.5–2 mg per injection
• Frequency: 1–3 times weekly depending on application
• Best for: Systemic anti-inflammatory effects, gut repair, and joint/autoimmune applications

Oral Administration (Gut-Targeted Use)

• Dose: 1–20 mg daily (exploratory range)
• Best for: Gastrointestinal-specific applications — IBD, leaky gut, colitis
• Oral delivery is viable because KPV is stable in the GI tract and retains activity in gut tissue

Topical Administration (Skin-Targeted Use)

• Applied directly to affected skin area 1–2 times daily
• Best for: Eczema, psoriasis, dermatitis, wound healing, post-procedure recovery

Cycle:

• Acute conditions: 4–6 week course, reassess
• Chronic inflammatory conditions: longer protocols under medical supervision
• No mandatory off period established; cycling is generally recommended

Injection Sites (SubQ): Abdomen, upper thigh, or glute — rotate with each injection

Reconstitution:

• Add bacteriostatic water to lyophilised powder
• Swirl gently — never shake
• Refrigerate at 2–8°C and use within 28 days
• Discard if solution is cloudy or contains visible particles

---

Side Effects & Safety

KPV has demonstrated an excellent safety profile in both preclinical and limited experimental human use. As a small, naturally occurring tripeptide fragment of α-MSH, it is well tolerated across multiple delivery routes.

General tolerability:

• Oral administration: stable in the GI tract, no toxic effects at typical research doses in animal studies
• Topical application: no significant local irritation or adverse reactions reported
• Injectable use: no major systemic toxicity in preclinical studies, even at relatively high mg/kg dosing

Compared to steroidal anti-inflammatories: KPV modulates the immune response without suppressing it the way corticosteroids do — eliminating the risks of adrenal suppression, tissue breakdown, skin thinning, and increased infection susceptibility associated with steroid use.

Possible side effects:

• Mild injection site redness or discomfort — resolves with site rotation
• Rare: mild nausea with oral administration at higher doses — usually transient

Important safety considerations:

• Autoimmune conditions — KPV's immune-modulating properties may require medical supervision in individuals with diagnosed autoimmune diseases or those on immunosuppressive therapy
• Organ transplant recipients — immune modulation could theoretically affect transplant tolerance; specialist consultation required
• Pregnancy and breastfeeding — avoid use; safety data not established
• Stacking with other immune-modulating peptides — combined effects on immune function warrant medical oversight

---

Synergy Stacks

Gold Standard Gut Repair: KPV + BPC-157 The strongest gut healing combination in the research peptide space. KPV inhibits gut inflammation at the NF-κB level; BPC-157 repairs the mucosal lining and restores vascularisation. Together they address both the inflammatory and structural dimensions of gut damage. Already combined in the KLOW-80 blend.

Full-Spectrum Gut Stack: KPV + BPC-157 + Glutathione Adds master antioxidant protection to the gut repair combination — targeting oxidative damage to intestinal epithelial cells alongside structural repair and inflammation resolution.

Systemic Inflammation Reset: KPV + Glutathione Broad systemic and cellular anti-inflammatory synergy — KPV works at the cytokine and receptor level; Glutathione provides antioxidant and cellular detoxification support.

Autoimmune Support: KPV + NAD+ Restores cellular energy and reduces inflammatory metabolic load alongside KPV's immune-modulating action. Useful for individuals with chronic inflammatory or autoimmune conditions.

Skin Repair: KPV (topical) + GHK-Cu (systemic) Topical KPV addresses surface inflammation, redness, and wound healing; systemic GHK-Cu stimulates collagen production and structural tissue repair from the inside out. A comprehensive skin healing protocol.

KLOW-80 Stack KPV is one of the four components in Riptide Health's KLOW-80 blend, alongside BPC-157, TB-500, and GHK-Cu — providing the immune-modulating and gut-specific anti-inflammatory dimension of that comprehensive healing formula.